## NEM: Newmont Corporation - XLB: Basic Materials

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.4% in lower entry zone (3.0-6.0%), top quartile (86th pct) cross-sectional ranking. Short-term MRS_5 (3.6%) confirms momentum alignment. Strong momentum (+3.5% 5-day acceleration). Outperforming sector by 6.2%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($87.43)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. BNP Paribas Exane Downgrades Newmont Corporation (NEM) to Neutral from Outperform**
- Source: Yahoo Finance | 20251208T235200 | Neutral | Relevance: 98%
-  BNP Paribas Exane downgraded Newmont Corporation (NEM) to Neutral from Outperform, setting a $97 price target, citing increasing momentum in the copper sector and a shift towards aluminum while maintaining a constructive view on gold. Conversely, UBS analysts reiterated Buy ratings on NEM, with price targets of A$190.00 and $125 respectively, anticipating continued gold demand fueled by central banks and investors through 2026. Newmont reported strong Q3 2025 results, including record free cash flow, and announced commercial production at its Ahafo North project in Ghana, expected to contribute significantly to gold output.

**2. BNP Paribas Exane Downgrades Newmont Corporation (NEM) to Neutral from Outperform**
- Source: Finviz | 20251208T235200 | Neutral | Relevance: 98%
-  BNP Paribas Exane downgraded Newmont Corporation (NEM) to Neutral from Outperform on December 5, setting a target price of $97, citing momentum in the copper sector for 2026 and shifting preferences in gold. This contrasts with recent Buy ratings and higher price targets from UBS analysts. Newmont reported strong Q3 2025 performance with record free cash flow and achieved commercial production at its Ahafo North project.

**3. BofA Raises PT on Newmont (NEM) Stock**
- Source: Insider Monkey | 20251209T111900 | Somewhat-Bullish | Relevance: 98%
-  BofA analyst Lawson Winder has increased the price target for Newmont Corporation (NYSE: NEM) to $118 from $115, maintaining a “Buy” rating, citing a refresh of price forecasts for North American Metals & Mining stocks. Despite a challenging macroeconomic environment due to China's slowing commodity demand, the analyst anticipates a potential rebound in demand from the US and Europe. Newmont reported a decrease in Q3 2025 gold production but saw an increase in overall sales compared to Q3 2024.

**4. Newmont Corp. stock outperforms competitors on strong trading day**
- Source: MarketWatch | 20251209T163000 | Bullish | Relevance: 98%
-  Newmont Corp. (NEM) shares rallied 5.72% to $94.09 on Tuesday, contrasting with a general market downturn where the S&P 500 Index and Dow Jones Industrial Average experienced declines. This strong performance ended a two-day losing streak for Newmont. The article highlights the company's outperformance relative to the broader market and its competitors on a challenging trading day.

**5. BNP Paribas Exane Downgrades Newmont Corporation (NEM) to Neutral from Outperform**
- Source: Insider Monkey | 20251208T235200 | Neutral | Relevance: 98%
-  BNP Paribas Exane downgraded Newmont Corporation (NEM) to Neutral from Outperform, setting a price target of $97, citing the copper sector's momentum and a preference switch towards aluminum and away from gold, despite continued demand for gold in 2026. This downgrade contrasts with recent Buy ratings and raised price targets from UBS analysts. Newmont reported strong Q3 2025 performance with record free cash flow and the commercial production of its Ahafo North project in Ghana.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-01 | UBS | $125 | $106 | +18% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-01 | UBS | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 6 ($2.91M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.2% (-1.1%)
- Blackrock Inc.: 11.2% (+3.4%)
- State Street Corpora: 4.5% (-0.3%)
- Geode Capital Manage: 2.4% (+3.9%)
- Van Eck Associates C: 2.2% (-42.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +3.5% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.91 elevated, pricing in significant growth expectations. Forward P/E 12.6x attractive for 20% earnings growth. Quality metrics strong (ROE 23%, ROA 10%, margin 33%). Balance sheet: strong liquidity (2.0x), $1.6B free cash flow. Analyst sentiment positive (1 raises, avg +18%). Insider selling cluster ($2.9M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $103.4B |
| Beta | 0.43 |
| 52W Range | $36.86 - $98.58 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.91 |
| Forward P/E | 12.6 |
| Current P/E | 15.0 |
| YoY Growth | 19.9% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from -0.1% to 3.4% (+3.5% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 86th percentile. MRS_5 at 3.6% confirms short-term momentum alignment. Outperforming sector by 6.2pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.42% (CS: 86) | Strong |
| RSI_14 | 61.6 | Neutral |
| MACD Histogram | 0.35 | Bullish |
| vs SMA20 | 1.059x | Above |
| vs SMA50 | 1.080x | Above |
| vs SMA200 | 1.428x | Above |

### Decision

- **Verdict:** BUY
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $94.09
- **Stop Loss:** $87.43 (7.1% risk)
- **Target:** $104.08 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 75
- **Position Value:** $7,056.75
- **Portfolio %:** 7.06%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not inverted—indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-19 (Est: $1.79)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.44 | $1.71 | +18.8% |
| 2025Q2 | $1.16 | $1.43 | +22.9% |
| 2025Q1 | $0.91 | $1.25 | +37.1% |
| 2024Q4 | $1.03 | $1.40 | +35.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*